- Events Past EventsJune 2-6, McCormick Place, Chicago, IL The ASCO Annual Meeting offers informative educational and scientific sessions that highlight the latest in cancer care treatments. VIEW PRELIMINARY PROGRAM Check out the PreliminaryRead more
- Events Past Events22-24 May 2017, Leiden University Medical Centre, Leiden, The Netherlands Recognition of the skin by vaccinologists as an ideal anatomical target has gathered momentum in the past decade. The premiseRead more
- Events Past EventsMeet us in D.C.! May 12-16, 2017 Washington Convention Center Great science awaits you at this, the largest annual gathering of immunologists worldwide. At IMMUNOLOGY 2017™, you’ll hear from globalRead more
STIC 2017 Annual Meeting and Pre Conference Programs
Events Past EventsWednesday, November 8 - Sunday, November 12, 2017 Save the Date! The Society for Immunotherapy of Cancer (SITC) cordially asks you to save the date of our 32nd Annual MeetingRead more2017 BIO International Convention
Events Past EventsBIO Returns to California Location: San Diego Convention Center; 111 W Harbor Dr., San Diego, CA 92101 There’s no better place to connect with biotech’s top people and most innovativeRead moreImmunomic Therapeutics licenses Hopkins-developed vaccine technology for $300 million
PressImmunomic Therapeutics, a biotechnology company developing a new type of vaccine based on Johns Hopkins research, has reached a $300 million deal licensing its technology to Japanese company Astellas Pharma.Read moreBioWorld’s Partner in Focus: Immunomic Therapeutics, Inc.
HighlightsTHE REMARKABLE SCIENCE BEHIND LAMP TECHNOLOGY – AND ITS POTENTIAL TO TREAT HUMAN DISEASE The body’s own immune system is its best defense against everything from allergies to cancerRead moreImmunomic Therapeutics (ITI) Named “Company of the Year” by the Tech Council of Maryland
Press ReleasesROCKVILLE, Md., May 16, 2016 /PRNewswire/ -- At the North Bethesda Marriott, Maryland's leading technology and life science companies gathered to celebrate recent successes from the most innovative teams in theRead moreImmunomic Therapeutics Gives Back to Maryland Biotech Community
Press ReleasesNovember 08, 2016 07:00 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, today announced they are now accepting applications for their Cancer DiscoveryRead moreFierce Pharma Article on Reprogramming the Immune System To Fight Cancer
Highlightshttps://www.fiercepharma.com/sponsored/reprogramming-immune-system-to-fight-cancerhttps://www.fiercepharma.com/sponsored/reprogramming-immune-system- Reprogramming the Immune System To Fight Cancer Sponsored by Immunomic Therapeutics, Inc. Nov 14, 2016 12:00am By Teri Heiland, Ph.D and Bill Watt, Ph.D. Cancer immunotherapy marks a turningRead moreThe Japan Times Highlights Immunomics’ LAMP-Vax
HighlightsClouds of pollen emanate from cedar trees in Sagamihara, Kanagawa Prefecture, in 2005. | KYODO LIFESTYLE When pollen attacks! Experts reveal new approaches to combating hay fever BY TOMOKO OTAKERead moreWashington Post – Chasing Cancer Summit
Events Past EventsImmunomic is pleased to share that CEO Dr. Bill Hearl served as a panelist during The Washington Post’s Chasing Cancer Summit in Washington, D.C. on Tuesday, Dec. 7th. The event was focusedRead more
